FORM N-PX
ANNUAL REPORT OF PROXY VOTING RECORD OF REGISTERED MANAGEMENT INVESTMENT COMPANY
INVESTMENT COMPANY ACT FILE NUMBER: 811-03010
EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER: Fidelity Advisor Series VII
Fund Name: Fidelity Advisor Biotechnology Fund
82 DEVONSHIRE STREET, BOSTON, MA 02109
(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES) (ZIP CODE)
ERIC D. ROITER, SECRETARY, 82 DEVONSHIRE STREET, BOSTON, MA 02109
(NAME AND ADDRESS OF AGENT FOR SERVICE)
REGISTRANT'S TELEPHONE NUMBER, INCLUDING AREA CODE: 617-563-7000
DATE OF FISCAL YEAR END: JULY 31
DATE OF REPORTING PERIOD: 06/30/2005
SIGNATURES
PURSUANT TO THE REQUIREMENTS OF THE INVESTMENT COMPANY ACT OF 1940, THE REGISTRANT HAS DULY CAUSED THIS REPORT TO BE SIGNED ON ITS BEHALF BY THE UNDERSIGNED, THERE UNTO DULY AUTHORIZED.
Fidelity Advisor Series VII
BY: /s/ CHRISTINE REYNOLDS
-----------------------------------------------------
CHRISTINE REYNOLDS, TREASURER, FIDELITY MANAGEMENT & RESEARCH COMPANY
DATE: 08/09/2005 09:38:53 AM
EXHIBIT A
VOTE SUMMARY REPORT
Fidelity Advisor Biotechnology Fund
07/01/2004 - 06/30/2005
Note: The Security ID will be the CUSIP (Committee on Uniform Securities Identification Procedures) when available. When CUSIP is not available, an alternate identifier, e.g., CINS, will be provided.
| ISSUER NAME: ACTELION LTD., ALLSCHWIL MEETING DATE: 04/14/2005 | ||||
| TICKER: -- SECURITY ID: H0032X135 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1 | THE PRACTICE OF SHARE BLOCKING VARIES WIDELY IN THIS MARKET. PLEASE CONTACT YOUR ADP CLIENT SERVICE REPRESENTATIVE TO OBTAIN BLOCKING INFORMATION FOR YOUR ACCOUNTS. | N/A | N/A | N/A |
| 2 | PLEASE NOTE THAT THIS IS THE PART II OF THE MEETING NOTICE SENT UNDER MEETING 221726, INCLUDING THE AGENDA. TO VOTE IN THE UPCOMING MEETING, YOUR NAME MUST BE NOTIFIED TO THE COMPANY REGISTRAR AS BENEFICIAL OWNER BEFORE THE RE-REGISTRATION DEADLINE. PLEASE NOTE THAT THOSE INSTRUCTIONS THAT ARE SUBMITTED AFTER THE ADP CUTOFF DATE WILL BE PROCESSED ON A BEST EFFORT BASIS. THANK YOU. | N/A | N/A | N/A |
| 3 | PLEASE NOTE THAT THIS IS AN AGM. THANK YOU. | N/A | N/A | N/A |
| 4 | RECEIVE THE BUSINESS REPORT OF THE BOARD OF DIRECTORS FOR THE BUSINESS YEAR 2004 CONSISTING OF THE ANNUAL REPORT AS WELL AS THE ANNUAL STATUTORY AND THE CONSOLIDATED ACCOUNTS | Management | Unknown | Take No Action |
| 5 | RECEIVE THE REPORT OF THE AUDITORS OF THE ANNUAL STATUTORY AND THE CONSOLIDATED ACCOUNTS AS OF 31 DEC 2004 | Management | Unknown | Take No Action |
| 6 | APPROVE THE BUSINESS REPORT CONSISTING OF THE ANNUAL REPORT AS WELL AS THE ANNUAL STATUTORY ACCOUNTS AND CONSOLIDATED ACCOUNTS AS OF 31 DEC 2004 | Management | Unknown | Take No Action |
| 7 | APPROVE THE ANNUAL ACCOUNTS AS OF 31 DEC 2004 | Management | Unknown | Take No Action |
| 8 | GRANT DISCHARGE TO THE BOARD OF DIRECTORS AND OF THE EXECUTIVE MANAGEMENT | Management | Unknown | Take No Action |
| 9 | RE-ELECT MR. ROB CAWTHORN AS A BOARD MEMBER | Management | Unknown | Take No Action |
| 10 | RE-ELECT DR. JEAN-PAUL CLOZEL AS BOARD MEMBER | Management | Unknown | Take No Action |
| 11 | ELECT MR. JUHANI ANTTILA AS A BOARD MEMBER | Management | Unknown | Take No Action |
| 12 | RE-APPOINT PRICEWATERHOUSECOOPERS AG AS THE AUDITORS OF THE STATUTORY AND THE CONSOLIDATED ACCOUNTS FOR THE BUSINESS YEAR 2005 | Management | Unknown | Take No Action |
| 13 | AMEND THE COMPANY S CAPITAL STRUCTURE; CONSEQUENTLY, AMEND ARTICLE 3A(1) OF THE ARTICLES OF ASSOCIATION TO INCREASE THE CONDITIONAL CAPITAL TO BE USED IN CONNECTION WITH EMPLOYEE STOCK OPTIONS BY CHF 2,500,000 1,000,000 SHARES1 | Management | Unknown | Take No Action |
| 14 | AMEND THE COMPANY S CAPITAL STRUCTURE; CONSEQUENTLY, AMEND ARTICLE 3B(1) OF THE ARTICLES OF ASSOCIATION TO INCREASE THE AUTHORIZED CAPITAL BY CHF 17,500,000 FROM CHF 10,000,000 (4,000,000 SHARES) TO CHF 27,500,000 (11,000,000 SHARES)1 | Management | Unknown | Take No Action |
| 1. Fidelity displays agenda items and descriptions, including the use of characters (such as page numbers, percentage and pound signs, ampersands and, in particular, asterisks and other footnote designations) as they are provided by the issuer and the vote processing agent. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: AFFYMETRIX, INC. MEETING DATE: 06/16/2005 | ||||
| TICKER: AFFX SECURITY ID: 00826T108 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1.1 | ELECT STEPHEN P.A. FODOR, PHD AS A DIRECTOR | Management | For | For |
| 1.2 | ELECT PAUL BERG, PHD AS A DIRECTOR | Management | For | For |
| 1.3 | ELECT SUSAN DESMOND-HELLMANN AS A DIRECTOR | Management | For | For |
| 1.4 | ELECT JOHN D. DIEKMAN, PHD AS A DIRECTOR | Management | For | For |
| 1.5 | ELECT VERNON R. LOUCKS, JR. AS A DIRECTOR | Management | For | For |
| 1.6 | ELECT SUSAN E. SIEGEL AS A DIRECTOR | Management | For | For |
| 1.7 | ELECT DAVID B. SINGER AS A DIRECTOR | Management | For | For |
| 1.8 | ELECT JOHN A. YOUNG AS A DIRECTOR | Management | For | For |
| 2 | TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF THE COMPANY FOR THE FISCAL YEAR ENDING DECEMBER 31, 2005.1 | Management | For | For |
| 1. Fidelity displays agenda items and descriptions, including the use of characters (such as page numbers, percentage and pound signs, ampersands and, in particular, asterisks and other footnote designations) as they are provided by the issuer and the vote processing agent. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: ALKERMES, INC. MEETING DATE: 09/23/2004 | ||||
| TICKER: ALKS SECURITY ID: 01642T108 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1.1 | ELECT FLOYD E. BLOOM AS A DIRECTOR | Management | For | For |
| 1.2 | ELECT ROBERT A. BREYER AS A DIRECTOR | Management | For | For |
| 1.3 | ELECT GERRI HENWOOD AS A DIRECTOR | Management | For | For |
| 1.4 | ELECT PAUL J. MITCHELL AS A DIRECTOR | Management | For | For |
| 1.5 | ELECT RICHARD F. POPS AS A DIRECTOR | Management | For | For |
| 1.6 | ELECT ALEXANDER RICH AS A DIRECTOR | Management | For | For |
| 1.7 | ELECT PAUL SCHIMMEL AS A DIRECTOR | Management | For | For |
| 1.8 | ELECT MARK B. SKALETSKY AS A DIRECTOR | Management | For | For |
| 1.9 | ELECT MICHAEL A. WALL AS A DIRECTOR | Management | For | For |
| 2 | TO APPROVE AN AMENDMENT TO THE 1999 STOCK OPTION PLAN TO INCREASE TO 16,900,000 THE NUMBER OF SHARES ISSUABLE UPON EXERCISE OF OPTIONS GRANTED THEREUNDER, AN INCREASE OF 2,500,000 SHARES. | Management | For | For |
| ISSUER NAME: AMGEN INC. MEETING DATE: 05/11/2005 | ||||
| TICKER: AMGN SECURITY ID: 031162100 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1.1 | ELECT DR. DAVID BALTIMORE AS A DIRECTOR | Management | For | For |
| 1.2 | ELECT MS. JUDITH C. PELHAM AS A DIRECTOR | Management | For | For |
| 1.3 | ELECT MR. KEVIN W. SHARER AS A DIRECTOR | Management | For | For |
| 2 | TO RATIFY THE SELECTION OF ERNST & YOUNG LLP AS THE COMPANY S INDEPENDENT REGISTERED PUBLIC ACCOUNTANTS FOR THE YEAR ENDING DECEMBER 31, 2005.1 | Management | For | For |
| 3 | STOCKHOLDER PROPOSAL #1 (IN VITRO TESTING)1 | Shareholder | Against | Against |
| 4 | STOCKHOLDER PROPOSAL #2 (EXECUTIVE COMPENSATION)1 | Shareholder | Against | Against |
| 5 | STOCKHOLDER PROPOSAL #3 (STOCK RETENTION)1 | Shareholder | Against | Against |
| 1. Fidelity displays agenda items and descriptions, including the use of characters (such as page numbers, percentage and pound signs, ampersands and, in particular, asterisks and other footnote designations) as they are provided by the issuer and the vote processing agent. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: AMYLIN PHARMACEUTICALS, INC. MEETING DATE: 05/25/2005 | ||||
| TICKER: AMLN SECURITY ID: 032346108 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1.1 | ELECT VAUGHN D. BRYSON AS A DIRECTOR | Management | For | For |
| 1.2 | ELECT JOSEPH C. COOK, JR. AS A DIRECTOR | Management | For | For |
| 1.3 | ELECT GINGER L. GRAHAM AS A DIRECTOR | Management | For | For |
| 1.4 | ELECT HOWARD E. GREENE, JR. AS A DIRECTOR | Management | For | For |
| 1.5 | ELECT TERRANCE H. GREGG AS A DIRECTOR | Management | For | For |
| 1.6 | ELECT JAY S. SKYLER AS A DIRECTOR | Management | For | For |
| 1.7 | ELECT JOSEPH P. SULLIVAN AS A DIRECTOR | Management | For | For |
| 1.8 | ELECT THOMAS R. TESTMAN AS A DIRECTOR | Management | For | For |
| 1.9 | ELECT JAMES N. WILSON AS A DIRECTOR | Management | For | For |
| 2 | TO APPROVE AN INCREASE OF 7,000,000 SHARES IN THE AGGREGATE NUMBER OF SHARES OF THE COMPANY S COMMON STOCK AUTHORIZED FOR ISSUANCE UNDER THE COMPANY S 2001 EQUITY INCENTIVE PLAN. | Management | For | Against |
| 3 | TO RATIFY THE SELECTION OF ERNST & YOUNG LLP AS INDEPENDENT AUDITORS OF THE COMPANY FOR ITS FISCAL YEAR ENDING DECEMBER 31, 2005.1 | Management | For | For |
| 1. Fidelity displays agenda items and descriptions, including the use of characters (such as page numbers, percentage and pound signs, ampersands and, in particular, asterisks and other footnote designations) as they are provided by the issuer and the vote processing agent. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: BIOGEN IDEC INC. MEETING DATE: 06/03/2005 | ||||
| TICKER: BIIB SECURITY ID: 09062X103 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1.1 | ELECT THOMAS F. KELLER AS A DIRECTOR | Management | For | For |
| 1.2 | ELECT WILLIAM H. RASTETTER AS A DIRECTOR | Management | For | For |
| 1.3 | ELECT LYNN SCHENK AS A DIRECTOR | Management | For | For |
| 1.4 | ELECT PHILLIP A. SHARP AS A DIRECTOR | Management | For | For |
| 2 | TO RATIFY THE SELECTION OF PRICEWATERHOUSECOOPERS LLP AS THE COMPANY S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2005. | Management | For | For |
| 3 | TO APPROVE OUR 2005 OMNIBUS EQUITY PLAN. | Management | For | Against |
| 4 | TO APPROVE THE AMENDMENT AND RESTATEMENT OF OUR 1995 EMPLOYEE STOCK PURCHASE PLAN, INCLUDING AN INCREASE IN THE NUMBER OF SHARES AVAILABLE FOR ISSUANCE UNDER THE PLAN FROM 4,170,000 SHARES TO 6,170,000 SHARES. | Management | For | For |
| ISSUER NAME: BIOMARIN PHARMACEUTICAL INC. MEETING DATE: 06/28/2005 | ||||
| TICKER: BMRN SECURITY ID: 09061G101 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1.1 | ELECT JEAN-JACQUES BIENAIME AS A DIRECTOR | Management | For | For |
| 1.2 | ELECT FRANZ L. CRISTIANI AS A DIRECTOR | Management | For | For |
| 1.3 | ELECT ELAINE J. HERON AS A DIRECTOR | Management | For | For |
| 1.4 | ELECT PIERRE LAPALME AS A DIRECTOR | Management | For | For |
| 1.5 | ELECT ERICH SAGER AS A DIRECTOR | Management | For | For |
| 1.6 | ELECT JOHN URQUHART AS A DIRECTOR | Management | For | For |
| 1.7 | ELECT GWYNN R. WILLIAMS AS A DIRECTOR | Management | For | For |
| 2 | PROPOSAL TO RATIFY THE SELECTION BY THE BOARD OF DIRECTORS OF KPMG LLP AS THE COMPANY S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE YEAR ENDING DECEMBER 31, 2005. | Management | For | For |
| ISSUER NAME: CELGENE CORPORATION MEETING DATE: 06/15/2005 | ||||
| TICKER: CELG SECURITY ID: 151020104 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1.1 | ELECT JOHN W. JACKSON AS A DIRECTOR | Management | For | For |
| 1.2 | ELECT SOL J. BARER, PHD AS A DIRECTOR | Management | For | For |
| 1.3 | ELECT ROBERT J. HUGIN AS A DIRECTOR | Management | For | For |
| 1.4 | ELECT JACK L. BOWMAN AS A DIRECTOR | Management | For | For |
| 1.5 | ELECT FRANK T. CARY AS A DIRECTOR | Management | For | For |
| 1.6 | ELECT MICHAEL D. CASEY AS A DIRECTOR | Management | For | For |
| 1.7 | ELECT ARTHUR HULL HAYES JR MD AS A DIRECTOR | Management | For | For |
| 1.8 | ELECT GILLA KAPLAN, PHD AS A DIRECTOR | Management | For | For |
| 1.9 | ELECT RICHARD C.E. MORGAN AS A DIRECTOR | Management | For | For |
| 1.10 | ELECT WALTER L. ROBB, PHD AS A DIRECTOR | Management | For | For |
| 2 | TO AMEND THE 1998 STOCK INCENTIVE PLAN TO INCREASE THE NUMBER OF SHARES THAT MAY BE SUBJECT TO AWARDS GRANTED THEREUNDER FROM 25,000,000 TO 31,000,000 AND TO DECREASE THE NUMBER OF SHARES THAT MAY BE USED FOR AWARDS OF RESTRICTED STOCK OR PERFORMANCE- BASED AWARDS DENOMINATED IN SHARES OF COMMON STOCK FROM 1,700,000 TO 750,000. | Management | For | For |
| 3 | TO AMEND THE 1995 NON-EMPLOYEE DIRECTORS INCENTIVE PLAN TO INCREASE THE NUMBER OF SHARES THAT MAY BE SUBJECT TO OPTIONS GRANTED THEREUNDER FROM 3,600,000 TO 3,850,000, AND TO EXTEND THE PERIOD UNDER WHICH OPTIONS MAY BE GRANTED UNTIL JUNE 30, 2015. | Management | For | For |
| 4 | TO RATIFY THE APPOINTMENT OF KPMG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2005. | Management | For | For |
| ISSUER NAME: CEPHALON, INC. MEETING DATE: 05/18/2005 | ||||
| TICKER: CEPH SECURITY ID: 156708109 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1.1 | ELECT FRANK BALDINO JR. PH.D. AS A DIRECTOR | Management | For | For |
| 1.2 | ELECT WILLIAM P. EGAN AS A DIRECTOR | Management | For | For |
| 1.3 | ELECT MARTYN D. GREENACRE AS A DIRECTOR | Management | For | For |
| 1.4 | ELECT VAUGHN M. KAILIAN AS A DIRECTOR | Management | For | For |
| 1.5 | ELECT CHARLES A. SANDERS M.D. AS A DIRECTOR | Management | For | For |
| 1.6 | ELECT GAIL R. WILENSKY PH.D. AS A DIRECTOR | Management | For | For |
| 1.7 | ELECT DENNIS L. WINGER AS A DIRECTOR | Management | For | For |
| 1.8 | ELECT HORST WITZEL DR.-ING. AS A DIRECTOR | Management | For | For |
| 2 | RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTANTS FOR THE FISCAL YEAR ENDED DECEMBER 31, 2005. | Management | For | For |
| ISSUER NAME: CURIS, INC. MEETING DATE: 06/01/2005 | ||||
| TICKER: CRIS SECURITY ID: 231269101 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1.1 | ELECT SUSAN B. BAYH AS A DIRECTOR | Management | For | For |
| 1.2 | ELECT MARTYN D. GREENACRE AS A DIRECTOR | Management | For | For |
| 1.3 | ELECT KENNETH I. KAITIN AS A DIRECTOR | Management | For | For |
| 2 | TO RATIFY THE APPOINTMENT OF PRICEWATERHOUSECOOPERS LLP AS THE COMPANY S INDEPENDENT PUBLIC ACCOUNTANTS FOR THE CURRENT FISCAL YEAR. | Management | For | For |
| ISSUER NAME: CYBERONICS, INC. MEETING DATE: 09/28/2004 | ||||
| TICKER: CYBX SECURITY ID: 23251P102 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1.1 | ELECT ROBERT P. CUMMINS AS A DIRECTOR | Management | For | For |
| 1.2 | ELECT REESE S. TERRY, JR. AS A DIRECTOR | Management | For | For |
| 1.3 | ELECT GUY C. JACKSON AS A DIRECTOR | Management | For | For |
| 1.4 | ELECT STANLEY H. APPEL, MD AS A DIRECTOR | Management | For | For |
| 1.5 | ELECT TONY COELHO AS A DIRECTOR | Management | For | For |
| 1.6 | ELECT MICHAEL J. STRAUSS, MD AS A DIRECTOR | Management | For | For |
| 1.7 | ELECT ALAN J. OLSEN AS A DIRECTOR | Management | For | For |
| 1.8 | ELECT RONALD A. MATRICARIA AS A DIRECTOR | Management | For | For |
| 2 | PROPOSAL TO APPROVE THE CYBERONICS, INC. 2004 STOCK PLAN. | Management | For | Against |
| 3 | PROPOSAL TO RATIFY THE APPOINTMENT OF KPMG LLP AS THE COMPANY S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE 2005 FISCAL YEAR. | Management | For | For |
| ISSUER NAME: CYBERONICS, INC. MEETING DATE: 05/19/2005 | ||||
| TICKER: CYBX SECURITY ID: 23251P102 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1 | PROPOSAL TO APPROVE THE CYBERONICS, INC. 2005 STOCK PLAN. | Management | For | For |
| ISSUER NAME: CYPRESS BIOSCIENCE, INC. MEETING DATE: 08/17/2004 | ||||
| TICKER: CYPB SECURITY ID: 232674507 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1.1 | ELECT SAMUEL D. ANDERSON AS A DIRECTOR | Management | For | For |
| 1.2 | ELECT JACK H. VAUGHN AS A DIRECTOR | Management | For | For |
| 2 | TO RATIFY THE SELECTION OF ERNST & YOUNG LLP BY THE AUDIT COMMITTEE OF THE COMPANY S BOARD OF DIRECTORS AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF THE COMPANY FOR THE FISCAL YEAR ENDING DECEMBER 31, 2004.1 | Management | For | For |
| 1. Fidelity displays agenda items and descriptions, including the use of characters (such as page numbers, percentage and pound signs, ampersands and, in particular, asterisks and other footnote designations) as they are provided by the issuer and the vote processing agent. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: CYPRESS BIOSCIENCE, INC. MEETING DATE: 06/06/2005 | ||||
| TICKER: CYPB SECURITY ID: 232674507 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1.1 | ELECT JON W. MCGARITY AS A DIRECTOR | Management | For | For |
| 1.2 | ELECT JEAN-PIERRE MILLON AS A DIRECTOR | Management | For | For |
| 1.3 | ELECT GARY D. TOLLEFSON AS A DIRECTOR | Management | For | For |
| 2 | TO RATIFY THE SELECTION OF ERNST & YOUNG LLP BY THE AUDIT COMMITTEE OF THE COMPANY S BOARD OF DIRECTORS AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF THE COMPANY FOR THE FISCAL YEAR ENDING DECEMBER 31, 2005.1 | Management | For | For |
| 1. Fidelity displays agenda items and descriptions, including the use of characters (such as page numbers, percentage and pound signs, ampersands and, in particular, asterisks and other footnote designations) as they are provided by the issuer and the vote processing agent. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: DENDREON CORPORATION MEETING DATE: 06/08/2005 | ||||
| TICKER: DNDN SECURITY ID: 24823Q107 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1.1 | ELECT RICHARD B. BREWER* AS A DIRECTOR1 | Management | For | For |
| 1.2 | ELECT MITCHELL H. GOLD, MD.* AS A DIRECTOR1 | Management | For | For |
| 1.3 | ELECT RUTH B. KUNATH* AS A DIRECTOR1 | Management | For | For |
| 1.4 | ELECT M. BLAKE INGLE** AS A DIRECTOR1 | Management | For | For |
| 2 | APPROVAL OF AN INCREASE IN THE NUMBER OF AUTHORIZED SHARES OF THE COMPANY S COMMON STOCK, PAR VALUE $0.001 PER SHARE, FROM 80,000,000 SHARES TO 150,000,000 SHARES. | Management | For | For |
| 1. Fidelity displays agenda items and descriptions, including the use of characters (such as page numbers, percentage and pound signs, ampersands and, in particular, asterisks and other footnote designations) as they are provided by the issuer and the vote processing agent. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: DYAX CORP. MEETING DATE: 05/19/2005 | ||||
| TICKER: DYAX SECURITY ID: 26746E103 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1.1 | ELECT JAMES W. FORDYCE AS A DIRECTOR | Management | For | For |
| 1.2 | ELECT THOMAS L. KEMPNER AS A DIRECTOR | Management | For | For |
| 1.3 | ELECT MARY ANN GRAY AS A DIRECTOR | Management | For | For |
| 2 | TO AMEND DYAX S AMENDED AND RESTATED 1995 EQUITY INCENTIVE PLAN TO EXTEND THE PERIOD IN WHICH INCENTIVE STOCK OPTIONS MAY BE GRANTED TO ELIGIBLE EMPLOYEES UNDER THE PLAN. | Management | For | For |
| ISSUER NAME: ENZON PHARMACEUTICALS, INC. MEETING DATE: 12/07/2004 | ||||
| TICKER: ENZN SECURITY ID: 293904108 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1.1 | ELECT ROLF A. CLASSON AS A DIRECTOR | Management | For | For |
| 1.2 | ELECT ROBERT LEBUHN AS A DIRECTOR | Management | For | For |
| 2 | RATIFICATION OF THE SELECTION OF KPMG LLP TO AUDIT THE CONSOLIDATED FINANCIAL STATEMENTS OF THE COMPANY FOR THE FISCAL YEAR ENDING JUNE 30, 2005. | Management | For | For |
| ISSUER NAME: EPIX PHARMACEUTICALS, INC. MEETING DATE: 06/02/2005 | ||||
| TICKER: EPIX SECURITY ID: 26881Q101 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1.1 | ELECT C.F.O. GABRIELI AS A DIRECTOR | Management | For | For |
| 1.2 | ELECT MICHAEL D. WEBB AS A DIRECTOR | Management | For | For |
| 2 | PROPOSAL TO APPROVE THE AMENDMENT AND RESTATEMENT OF OUR EPIX PHARMACEUTICALS, INC. AMENDED AND RESTATED 1992 INCENTIVE PLAN, INCLUDING A 500,000 SHARE INCREASE IN THE NUMBER OF SHARES OF COMMON STOCK AVAILABLE FOR ISSUANCE UNDER SUCH PLAN. | Management | For | For |
| 3 | PROPOSAL TO APPROVE THE AMENDMENT AND RESTATEMENT OF OUR EPIX PHARMACEUTICALS, INC. AMENDED AND RESTATED 1996 DIRECTOR STOCK OPTION PLAN, INCLUDING A 100,000 SHARE INCREASE IN THE NUMBER OF SHARES OF COMMON STOCK AVAILABLE FOR ISSUANCE UNDER SUCH PLAN. | Management | For | For |
| 4 | PROPOSAL TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY S INDEPENDENT PUBLIC ACCOUNTANTS FOR THE FISCAL YEAR ENDING DECEMBER 31, 2005.1 | Management | For | For |
| 1. Fidelity displays agenda items and descriptions, including the use of characters (such as page numbers, percentage and pound signs, ampersands and, in particular, asterisks and other footnote designations) as they are provided by the issuer and the vote processing agent. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: FISHER SCIENTIFIC INTERNATIONAL INC. MEETING DATE: 08/02/2004 | ||||
| TICKER: FSH SECURITY ID: 338032204 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1 | ISSUANCE OF FISHER COMMON STOCK | Management | For | For |
| 2.1 | ELECT MICHAEL D. DINGMAN* AS A DIRECTOR1 | Management | For | For |
| 2.2 | ELECT CHARLES A SANDERS M.D.* AS A DIRECTOR1 | Management | For | For |
| 3 | RATIFY THE APPOINTMENT OF DELOITTE & TOUCHE LLP AS INDEPENDENT AUDITORS OF FISHER FOR THE FISCAL YEAR ENDING DECEMBER 31, 2004*1 | Management | For | For |
| 4 | ADJOURNMENT OF THE MEETING, IF NECESSARY, TO SOLICIT ADDITIONAL PROXIES. | Management | For | Abstain |
| 1. Fidelity displays agenda items and descriptions, including the use of characters (such as page numbers, percentage and pound signs, ampersands and, in particular, asterisks and other footnote designations) as they are provided by the issuer and the vote processing agent. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: GENENTECH, INC. MEETING DATE: 04/14/2005 | ||||
| TICKER: DNA SECURITY ID: 368710406 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1.1 | ELECT HERBERT W. BOYER AS A DIRECTOR | Management | For | For |
| 1.2 | ELECT WILLIAM M. BURNS AS A DIRECTOR | Management | For | For |
| 1.3 | ELECT ERICH HUNZIKER AS A DIRECTOR | Management | For | For |
| 1.4 | ELECT JONATHAN K.C. KNOWLES AS A DIRECTOR | Management | For | For |
| 1.5 | ELECT ARTHUR D. LEVINSON AS A DIRECTOR | Management | For | For |
| 1.6 | ELECT CHARLES A. SANDERS AS A DIRECTOR | Management | For | For |
| 2 | TO RATIFY THE SELECTION OF ERNST & YOUNG LLP AS INDEPENDENT AUDITOR OF GENENTECH FOR THE YEAR ENDING DECEMBER 31, 2005.1 | Management | For | For |
| 1. Fidelity displays agenda items and descriptions, including the use of characters (such as page numbers, percentage and pound signs, ampersands and, in particular, asterisks and other footnote designations) as they are provided by the issuer and the vote processing agent. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: GENTA INCORPORATED MEETING DATE: 06/23/2005 | ||||
| TICKER: GNTA SECURITY ID: 37245M207 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1.1 | ELECT R.P. WARRELL, JR., M.D. AS A DIRECTOR | Management | For | For |
| 1.2 | ELECT J.E. GROOPMAN, M.D. AS A DIRECTOR | Management | For | For |
| 1.3 | ELECT BETSY MCCAUGHEY, PH.D. AS A DIRECTOR | Management | For | For |
| 1.4 | ELECT PETER T. TATTLE AS A DIRECTOR | Management | For | For |
| 1.5 | ELECT D.D. VON HOFF, M.D. AS A DIRECTOR | Management | For | For |
| 1.6 | ELECT HARLAN J. WAKOFF AS A DIRECTOR | Management | For | For |
| 1.7 | ELECT DOUGLAS G. WATSON AS A DIRECTOR | Management | For | For |
| 1.8 | ELECT MICHAEL S. WEISS AS A DIRECTOR | Management | For | For |
| 2 | TO APPROVE AN AMENDMENT TO THE COMPANY S NON-EMPLOYEE DIRECTORS 1998 STOCK OPTION PLAN TO INCREASE THE NUMBER OF SHARES OF COMMON STOCK AUTHORIZED FOR ISSUANCE UNDER THE PLAN. | Management | For | For |
| 3 | TO RATIFY THE APPOINTMENT OF DELOITTE & TOUCHE LLP AS THE COMPANY S INDEPENDENT AUDITORS FOR THE FISCAL YEAR ENDING DECEMBER 31, 2005.1 | Management | For | For |
| 1. Fidelity displays agenda items and descriptions, including the use of characters (such as page numbers, percentage and pound signs, ampersands and, in particular, asterisks and other footnote designations) as they are provided by the issuer and the vote processing agent. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: GENZYME CORPORATION MEETING DATE: 05/26/2005 | ||||
| TICKER: GENZ SECURITY ID: 372917104 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1.1 | ELECT ROBERT J. CARPENTER AS A DIRECTOR | Management | For | For |
| 1.2 | ELECT CHARLES L. COONEY AS A DIRECTOR | Management | For | For |
| 2 | A PROPOSAL TO AMEND THE 1999 EMPLOYEE STOCK PURCHASE PLAN TO INCREASE THE NUMBER OF SHARES OF COMMON STOCK COVERED BY THE PLAN BY 1,000,000 SHARES. | Management | For | For |
| 3 | A PROPOSAL TO AMEND THE 2004 EQUITY INCENTIVE PLAN TO INCREASE THE NUMBER OF SHARES OF COMMON STOCK COVERED BY THE PLAN BY 10,000,000 SHARES. | Management | For | For |
| 4 | A PROPOSAL TO RATIFY THE SELECTION OF INDEPENDENT AUDITORS FOR 2005. | Management | For | For |
| 5 | A SHAREHOLDER PROPOSAL THAT DIRECTORS BE ELECTED ANNUALLY. | Shareholder | Against | For |
| ISSUER NAME: GILEAD SCIENCES, INC. MEETING DATE: 05/10/2005 | ||||
| TICKER: GILD SECURITY ID: 375558103 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1.1 | ELECT PAUL BERG AS A DIRECTOR | Management | For | For |
| 1.2 | ELECT ETIENNE F. DAVIGNON AS A DIRECTOR | Management | For | For |
| 1.3 | ELECT JAMES M. DENNY AS A DIRECTOR | Management | For | For |
| 1.4 | ELECT JOHN C. MARTIN AS A DIRECTOR | Management | For | For |
| 1.5 | ELECT GORDON E. MOORE AS A DIRECTOR | Management | For | For |
| 1.6 | ELECT NICHOLAS G. MOORE AS A DIRECTOR | Management | For | For |
| 1.7 | ELECT GEORGE P. SHULTZ AS A DIRECTOR | Management | For | For |
| 1.8 | ELECT GAYLE E. WILSON AS A DIRECTOR | Management | For | For |
| 2 | TO RATIFY THE SELECTION BY THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS OF ERNST & YOUNG LLP AS INDEPENDENT AUDITORS OF GILEAD FOR THE FISCAL YEAR ENDING DECEMBER 31, 2005.1 | Management | For | For |
| 3 | TO APPROVE AN AMENDMENT TO GILEAD S 2004 EQUITY INCENTIVE PLAN. | Management | For | Against |
| 4 | TO APPROVE A STOCKHOLDER PROPOSAL REQUESTING A REPORT ON HIV/AIDS, TUBERCULOSIS AND MALARIA PANDEMICS. | Shareholder | Against | Against |
| 1. Fidelity displays agenda items and descriptions, including the use of characters (such as page numbers, percentage and pound signs, ampersands and, in particular, asterisks and other footnote designations) as they are provided by the issuer and the vote processing agent. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: GUILFORD PHARMACEUTICALS INC. MEETING DATE: 05/04/2005 | ||||
| TICKER: GLFD SECURITY ID: 401829106 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1.1 | ELECT GEORGE L. BUNTING, JR. AS A DIRECTOR | Management | For | For |
| 1.2 | ELECT JOSEPH R. CHINNICI AS A DIRECTOR | Management | For | For |
| 1.3 | ELECT BARRY M. FOX AS A DIRECTOR | Management | For | For |
| 1.4 | ELECT ELIZABETH M. GREETHAM AS A DIRECTOR | Management | For | For |
| 1.5 | ELECT JOSEPH KLEIN III AS A DIRECTOR | Management | For | For |
| 1.6 | ELECT DEAN J. MITCHELL AS A DIRECTOR | Management | For | For |
| 1.7 | ELECT RONALD M. NORDMANN AS A DIRECTOR | Management | For | For |
| 1.8 | ELECT CRAIG R. SMITH, M.D. AS A DIRECTOR | Management | For | For |
| 1.9 | ELECT SOLOMON H. SNYDER, M.D. AS A DIRECTOR | Management | For | For |
| 1.10 | ELECT D.C. U'PRICHARD, PH.D. AS A DIRECTOR | Management | For | For |
| 2 | THE RATIFICATION OF THE SELECTION OF KPMG LLP AS THE COMPANY S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR 2005. | Management | For | For |
| 3 | THE AMENDMENT OF THE COMPANY S 2002 STOCK AWARD AND INCENTIVE PLAN (THE INCENTIVE PLAN ), ALL AS MORE FULLY DESCRIBED IN THE PROXY STATEMENT1 | Management | For | For |
| 4 | THE AMENDMENT OF THE COMPANY S 2002 EMPLOYEE STOCK PURCHASE PLAN (THE ESPP ) TO INCREASE THE NUMBER OF SHARES AVAILABLE FOR ISSUANCE UNDER THE ESPP BY 400,000 SHARES1 | Management | For | For |
| 1. Fidelity displays agenda items and descriptions, including the use of characters (such as page numbers, percentage and pound signs, ampersands and, in particular, asterisks and other footnote designations) as they are provided by the issuer and the vote processing agent. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: HARVARD BIOSCIENCE, INC. MEETING DATE: 05/19/2005 | ||||
| TICKER: HBIO SECURITY ID: 416906105 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1.1 | ELECT DAVID GREEN AS A DIRECTOR | Management | For | For |
| 1.2 | ELECT JOHN F. KENNEDY AS A DIRECTOR | Management | For | For |
| ISSUER NAME: ICAGEN, INC. MEETING DATE: 06/23/2005 | ||||
| TICKER: ICGN SECURITY ID: 45104P104 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1.1 | ELECT ANTHONY B. EVNIN AS A DIRECTOR | Management | For | For |
| 1.2 | ELECT DENNIS B. GILLINGS AS A DIRECTOR | Management | For | For |
| 1.3 | ELECT MARTIN A. SIMONETTI AS A DIRECTOR | Management | For | For |
| 2 | TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS ICAGEN S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE YEAR ENDING DECEMBER 31, 2005.1 | Management | For | For |
| 1. Fidelity displays agenda items and descriptions, including the use of characters (such as page numbers, percentage and pound signs, ampersands and, in particular, asterisks and other footnote designations) as they are provided by the issuer and the vote processing agent. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: ICOS CORPORATION MEETING DATE: 05/04/2005 | ||||
| TICKER: ICOS SECURITY ID: 449295104 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1.1 | ELECT TERESA BECK AS A DIRECTOR | Management | For | For |
| 1.2 | ELECT JACK W. SCHULER AS A DIRECTOR | Management | For | For |
| 1.3 | ELECT GARY L. WILCOX, PH.D. AS A DIRECTOR | Management | For | For |
| 2 | PROPOSAL TO APPROVE AMENDED AND RESTATED 1999 LONG-TERM INCENTIVE PLAN. | Management | For | Against |
| 3 | PROPOSAL TO APPROVE 2005 MANAGEMENT INCENTIVE PLAN. | Management | For | For |
| 4 | PROPOSAL TO APPROVE REINCORPORATION FROM DELAWARE TO WASHINGTON. | Management | For | For |
| 5 | PROPOSAL TO RATIFY THE APPOINTMENT OF KPMG LLP AS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE YEAR ENDING DECEMBER 31, 2005. | Management | For | For |
| 6 | STOCKHOLDER PROPOSAL REGARDING BOARD DECLASSIFICATION. | Shareholder | Against | For |
| ISSUER NAME: IMCLONE SYSTEMS INCORPORATED MEETING DATE: 06/15/2005 | ||||
| TICKER: IMCL SECURITY ID: 45245W109 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1.1 | ELECT ANDREW G. BODNAR AS A DIRECTOR | Management | For | For |
| 1.2 | ELECT WILLIAM W. CROUSE AS A DIRECTOR | Management | For | For |
| 1.3 | ELECT VINCENT T. DEVITA, JR. AS A DIRECTOR | Management | For | For |
| 1.4 | ELECT JOHN A. FAZIO AS A DIRECTOR | Management | For | For |
| 1.5 | ELECT JOSEPH L. FISCHER AS A DIRECTOR | Management | For | For |
| 1.6 | ELECT DAVID M. KIES AS A DIRECTOR | Management | For | For |
| 1.7 | ELECT DANIEL S. LYNCH AS A DIRECTOR | Management | For | For |
| 1.8 | ELECT WILLIAM R. MILLER AS A DIRECTOR | Management | For | For |
| 1.9 | ELECT DAVID SIDRANSKY AS A DIRECTOR | Management | For | For |
| 2 | RATIFICATION OF THE APPOINTMENT OF KPMG LLP TO SERVE AS THE COMPANY S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2005. | Management | For | For |
| 3 | APPROVAL OF THE IMCLONE SYSTEMS INCORPORATED 2005 STOCK INCENTIVE PLAN. | Management | For | Against |
| ISSUER NAME: IMMUNOGEN, INC. MEETING DATE: 11/09/2004 | ||||
| TICKER: IMGN SECURITY ID: 45253H101 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1.1 | ELECT MITCHEL SAYARE AS A DIRECTOR | Management | For | For |
| 1.2 | ELECT WALTER A. BLATTLER AS A DIRECTOR | Management | For | For |
| 1.3 | ELECT DAVID W. CARTER AS A DIRECTOR | Management | For | For |
| 1.4 | ELECT STUART F. FEINER AS A DIRECTOR | Management | For | For |
| 1.5 | ELECT MARK SKALETSKY AS A DIRECTOR | Management | For | For |
| 1.6 | ELECT JOSEPH J. VILLAFRANCA AS A DIRECTOR | Management | For | For |
| 2 | TO APPROVE THE PROPOSAL TO THE COMPANY S RESTATED STOCK OPTION PLAN TO INCREASE THE NUMBER OF SHARES RESERVED FOR THE GRANT OF OPTIONS FROM 7.35 MILLION TO 8.55 MILLION. | Management | For | For |
| ISSUER NAME: IMMUNOMEDICS, INC. MEETING DATE: 12/01/2004 | ||||
| TICKER: IMMU SECURITY ID: 452907108 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1.1 | ELECT DAVID M. GOLDENBERG AS A DIRECTOR | Management | For | For |
| 1.2 | ELECT CYNTHIA L. SULLIVAN AS A DIRECTOR | Management | For | For |
| 1.3 | ELECT MORTON COLEMAN AS A DIRECTOR | Management | For | For |
| 1.4 | ELECT MARVIN E. JAFFE AS A DIRECTOR | Management | For | For |
| 1.5 | ELECT BRIAN A. MARKISON AS A DIRECTOR | Management | For | For |
| 1.6 | ELECT MARY E. PAETZOLD AS A DIRECTOR | Management | For | For |
| 1.7 | ELECT RICHARD R. PIVIROTTO AS A DIRECTOR | Management | For | For |
| 2 | PROPOSAL TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING JUNE 30, 2005.1 | Management | For | For |
| 1. Fidelity displays agenda items and descriptions, including the use of characters (such as page numbers, percentage and pound signs, ampersands and, in particular, asterisks and other footnote designations) as they are provided by the issuer and the vote processing agent. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: INVITROGEN CORPORATION MEETING DATE: 04/20/2005 | ||||
| TICKER: IVGN SECURITY ID: 46185R100 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1.1 | ELECT BALAKRISHNAN S. IYER AS A DIRECTOR | Management | For | For |
| 1.2 | ELECT RONALD A. MATRICARIA AS A DIRECTOR | Management | For | For |
| 1.3 | ELECT W. ANN REYNOLDS, PH.D. AS A DIRECTOR | Management | For | For |
| 1.4 | ELECT JAY M. SHORT, PH.D. AS A DIRECTOR | Management | For | For |
| 2 | RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS INDEPENDENT AUDITORS OF THE COMPANY FOR FISCAL YEAR 2005.1 | Management | For | For |
| 1. Fidelity displays agenda items and descriptions, including the use of characters (such as page numbers, percentage and pound signs, ampersands and, in particular, asterisks and other footnote designations) as they are provided by the issuer and the vote processing agent. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: MEDAREX, INC. MEETING DATE: 05/19/2005 | ||||
| TICKER: MEDX SECURITY ID: 583916101 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1.1 | ELECT MR. MICHAEL A APPELBAUM AS A DIRECTOR | Management | For | For |
| 1.2 | ELECT DR. PATRICIA M. DANZON AS A DIRECTOR | Management | For | For |
| 2 | THE APPROVAL OF OUR 2005 EQUITY INCENTIVE PLAN. | Management | For | For |
| 3 | THE RATIFICATION OF THE SELECTION BY THE AUDIT COMMITTEE OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2005.1 | Management | For | For |
| 1. Fidelity displays agenda items and descriptions, including the use of characters (such as page numbers, percentage and pound signs, ampersands and, in particular, asterisks and other footnote designations) as they are provided by the issuer and the vote processing agent. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: MEDIMMUNE, INC. MEETING DATE: 05/19/2005 | ||||
| TICKER: MEDI SECURITY ID: 584699102 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1.1 | ELECT WAYNE T. HOCKMEYER AS A DIRECTOR | Management | For | For |
| 1.2 | ELECT DAVID M. MOTT AS A DIRECTOR | Management | For | For |
| 1.3 | ELECT DAVID BALTIMORE AS A DIRECTOR | Management | For | For |
| 1.4 | ELECT M. JAMES BARRETT AS A DIRECTOR | Management | For | For |
| 1.5 | ELECT JAMES H. CAVANAUGH AS A DIRECTOR | Management | For | For |
| 1.6 | ELECT BARBARA H. FRANKLIN AS A DIRECTOR | Management | For | For |
| 1.7 | ELECT GORDON S. MACKLIN AS A DIRECTOR | Management | For | For |
| 1.8 | ELECT GEORGE M. MILNE, JR. AS A DIRECTOR | Management | For | For |
| 1.9 | ELECT ELIZABETH H.S. WYATT AS A DIRECTOR | Management | For | For |
| 2 | TO APPROVE AN AMENDMENT TO THE 2004 STOCK INCENTIVE PLAN. | Management | For | Against |
| 3 | TO APPROVE AND RATIFY THE APPOINTMENT OF PRICEWATERHOUSECOOPERS LLP AS INDEPENDENT AUDITORS FOR 2005. | Management | For | For |
| ISSUER NAME: MERCK KGAA, DARMSTADT MEETING DATE: 03/31/2005 | ||||
| TICKER: -- SECURITY ID: D5357W103 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1 | PLEASE NOTE THAT THIS IS AN AGM. THANK YOU. | N/A | N/A | N/A |
| 2 | RECEIVE THE FINANCIAL STATEMENTS AND ANNUAL REPORT OF THE 2004 FY WITH THE REPORT OF THE SUPERVISORY BOARD THE GROUP FINANCIAL STATEMENTS AND THE GROUP ANNUAL REPORT | Management | Unknown | Take No Action |
| 3 | APPROVE THE FINANCIAL STATEMENTS FOR THE 2004 FY | Management | Unknown | Take No Action |
| 4 | APPROVE THE APPROPRIATION OF THE DISTRIBUTION PROFIT OF EUR 57,823,536.64 AS: PAYMENT OF A DIVIDEND OF EUR 0.80 PLUS A BONUS OF EUR 0.20 PER NO-PAR SHARE EUR 6,000,000 SHALL BE ALLOCATED TO THE REVENUE RESERVES EUR 1,240,657.64 SHALL BE CARRIED FORWARD EX-DIVIDEND AND PAYABLE DATE 01 APR 2005 | Management | Unknown | Take No Action |
| 5 | RATIFY THE ACTS OF THE COMPANY S MANAGEMENT | Management | Unknown | Take No Action |
| 6 | RATIFY THE ACTS OF THE SUPERVISORY BOARD | Management | Unknown | Take No Action |
| 7 | APPOINT KPMG, MANNHEIM AS THE AUDITORS FOR THE 2005 FY | Management | Unknown | Take No Action |
| 8 | APPROVE THE CONTROL AND PROFIT TRANSFER AGREEMENTS WITH THE COMPANY S WHOLLY-OWNED SUBSIDIARIES MERCK VIERTE ALLGEMEINE BETEILIGUNGSGESELLSCHAFT MBH, MERCK FUENFTE ALLGEMEINE BETEILIGUNGSGESELLSCHAFT MBH, AND MERCK 8. ALLGEMEINE BETEILIGUNGS GMBH, EFFECTIVE RETROACTIVELY FROM 01 JAN 2005, UNTIL AT LEAST 31 DEC 2009 | Management | Unknown | Take No Action |
| 9 | APPROVE THE REVISION OF SECTIONS 21(4)1 AND 32 OF THE ARTICLES OF ASSOCIATION1 | Management | Unknown | Take No Action |
| 10 | APPROVE TO INCREASE THE SHARE CAPITAL BY UP TO EUR 64,349,997.40 SHALL BE REVOKED; AUTHORIZE THE MANAGEMENT WITH THE CONSENT OF THE SUPERVISORY BOARD, TO INCREASE THE SHARE CAPITA BY UP TO EUR 64,349,997.40 THROUGH THE ISSUE OF NEW SHARES AGAINST PAYMENT IN CASH OR KIND, ON OR BEFORE 31 MAR 2010; SHAREHOLDERS SHALL BE GRANTED SUBSCRIPTION RIGHTS EXPECT FOR A CAPITAL INCREASE AGAINST CASH PAYMENT OF UP TO 10% OF THE SHARE CAPITAL IF THE NEW SHARES ARE ISSUED AT A PRICE NOT MATERIALLY BELOW THE MA... | Management | Unknown | Take No Action |
| 1. Fidelity displays agenda items and descriptions, including the use of characters (such as page numbers, percentage and pound signs, ampersands and, in particular, asterisks and other footnote designations) as they are provided by the issuer and the vote processing agent. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: MGI PHARMA, INC. MEETING DATE: 05/10/2005 | ||||
| TICKER: MOGN SECURITY ID: 552880106 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1.1 | ELECT ANDREW J. FERRARA AS A DIRECTOR | Management | For | For |
| 1.2 | ELECT EDWARD W. MEHRER AS A DIRECTOR | Management | For | For |
| 1.3 | ELECT HUGH E. MILLER AS A DIRECTOR | Management | For | For |
| 1.4 | ELECT LEON O. MOULDER, JR. AS A DIRECTOR | Management | For | For |
| 1.5 | ELECT DAVID B. SHARROCK AS A DIRECTOR | Management | For | For |
| 1.6 | ELECT WANETA C. TUTTLE, PH.D. AS A DIRECTOR | Management | For | For |
| 1.7 | ELECT ARTHUR L. WEAVER, M.D. AS A DIRECTOR | Management | For | For |
| 2 | TO RATIFY THE APPOINTMENT OF KPMG LLP AS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE COMPANY FOR THE FISCAL YEAR ENDING DECEMBER 31, 2005. | Management | For | For |
| ISSUER NAME: MILLENNIUM PHARMACEUTICALS, INC. MEETING DATE: 05/05/2005 | ||||
| TICKER: MLNM SECURITY ID: 599902103 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1.1 | ELECT MARK J. LEVIN AS A DIRECTOR | Management | For | For |
| 1.2 | ELECT A. GRANT HEIDRICH, III AS A DIRECTOR | Management | For | For |
| 1.3 | ELECT KENNETH E. WEG AS A DIRECTOR | Management | For | For |
| 2 | RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2005.1 | Management | For | For |
| 1. Fidelity displays agenda items and descriptions, including the use of characters (such as page numbers, percentage and pound signs, ampersands and, in particular, asterisks and other footnote designations) as they are provided by the issuer and the vote processing agent. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: NEUROCRINE BIOSCIENCES, INC. MEETING DATE: 05/25/2005 | ||||
| TICKER: NBIX SECURITY ID: 64125C109 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1.1 | ELECT GARY A. LYONS AS A DIRECTOR | Management | For | For |
| 2 | TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY S REGISTERED INDEPENDENT PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2005.1 | Management | For | For |
| 3 | TO APPROVE AN AMENDMENT TO THE COMPANY S 2003 INCENTIVE STOCK PLAN INCREASING THE NUMBER OF SHARES OF COMMON STOCK RESERVED FOR ISSUANCE FROM 2,300,000 TO 3,300,000 SHARES. | Management | For | Against |
| 1. Fidelity displays agenda items and descriptions, including the use of characters (such as page numbers, percentage and pound signs, ampersands and, in particular, asterisks and other footnote designations) as they are provided by the issuer and the vote processing agent. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: NPS PHARMACEUTICALS, INC. MEETING DATE: 05/12/2005 | ||||
| TICKER: NPSP SECURITY ID: 62936P103 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1.1 | ELECT MICHAEL W. BONNEY AS A DIRECTOR | Management | For | For |
| 1.2 | ELECT SANTO J. COSTA AS A DIRECTOR | Management | For | For |
| 1.3 | ELECT JOHN R. EVANS AS A DIRECTOR | Management | For | For |
| 1.4 | ELECT JAMES G. GRONINGER AS A DIRECTOR | Management | For | For |
| 1.5 | ELECT HUNTER JACKSON AS A DIRECTOR | Management | For | For |
| 1.6 | ELECT JOSEPH KLEIN III AS A DIRECTOR | Management | For | For |
| 1.7 | ELECT DONALD E. KUHLA AS A DIRECTOR | Management | For | For |
| 1.8 | ELECT THOMAS N. PARKS AS A DIRECTOR | Management | For | For |
| 1.9 | ELECT RACHEL R. SELISKER AS A DIRECTOR | Management | For | For |
| 1.10 | ELECT CALVIN R. STILLER AS A DIRECTOR | Management | For | For |
| 1.11 | ELECT PETER G. TOMBROS AS A DIRECTOR | Management | For | For |
| 2 | TO INCREASE BY 350,000 SHARES THE AGGREGATE NUMBER OF SHARES OF COMMON STOCK RESERVED FOR ISSUANCE UNDER THE COMPANY S 1994 EMPLOYEE STOCK PURCHASE PLAN. | Management | For | For |
| 3 | TO APPROVE THE NPS PHARMACEUTICALS, INC. 2005 OMNIBUS INCENTIVE PLAN AND THE RESERVATION OF 2,700,000 SHARES OF COMMON STOCK FOR ISSUANCE UNDER THE PLAN. | Management | For | Against |
| 4 | TO RATIFY THE SELECTION OF KPMG LLP AS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF THE COMPANY FOR ITS FISCAL YEAR ENDING DECEMBER 31, 2005. | Management | For | For |
| ISSUER NAME: OSCIENT PHARMACEUTICALS CORPORATION MEETING DATE: 05/25/2005 | ||||
| TICKER: OSCI SECURITY ID: 68812R105 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1.1 | ELECT DAVID B. SINGER AS A DIRECTOR | Management | For | For |
| 1.2 | ELECT LUKE B. EVNIN, PH.D. AS A DIRECTOR | Management | For | For |
| 1.3 | ELECT ROBERT J. HENNESSEY AS A DIRECTOR | Management | For | For |
| 1.4 | ELECT PAMELA J. KIRBY, PH.D. AS A DIRECTOR | Management | For | For |
| 1.5 | ELECT GARY PATOU, M.D. AS A DIRECTOR | Management | For | For |
| 1.6 | ELECT STEVEN M. RAUSCHER AS A DIRECTOR | Management | For | For |
| 1.7 | ELECT WILLIAM S. REARDON AS A DIRECTOR | Management | For | For |
| 1.8 | ELECT NORBERT G. RIEDEL PH.D. AS A DIRECTOR | Management | For | For |
| 1.9 | ELECT DAVID K. STONE AS A DIRECTOR | Management | For | For |
| 1.10 | ELECT JOHN E. VORIS AS A DIRECTOR | Management | For | For |
| 2 | TO RATIFY THE SELECTION OF ERNST & YOUNG LLP AS THE COMPANY S AUDITORS FOR THE YEAR ENDING DECEMBER 31, 2005.1 | Management | For | For |
| 1. Fidelity displays agenda items and descriptions, including the use of characters (such as page numbers, percentage and pound signs, ampersands and, in particular, asterisks and other footnote designations) as they are provided by the issuer and the vote processing agent. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: OSI PHARMACEUTICALS, INC. MEETING DATE: 03/16/2005 | ||||
| TICKER: OSIP SECURITY ID: 671040103 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1.1 | ELECT ROBERT A. INGRAM AS A DIRECTOR | Management | For | For |
| 1.2 | ELECT COLIN GODDARD, PH.D. AS A DIRECTOR | Management | For | For |
| 1.3 | ELECT MICHAEL G. ATIEH AS A DIRECTOR | Management | For | For |
| 1.4 | ELECT G. MORGAN BROWNE AS A DIRECTOR | Management | For | For |
| 1.5 | ELECT DARYL K. GRANNER, M.D. AS A DIRECTOR | Management | For | For |
| 1.6 | ELECT WALTER M LOVENBERG, PHD AS A DIRECTOR | Management | For | For |
| 1.7 | ELECT VIREN MEHTA AS A DIRECTOR | Management | For | For |
| 1.8 | ELECT HERBERT PINEDO, MD, PHD AS A DIRECTOR | Management | For | For |
| 1.9 | ELECT SIR MARK RICHMOND, PH.D AS A DIRECTOR | Management | For | For |
| 1.10 | ELECT JOHN P. WHITE AS A DIRECTOR | Management | For | For |
| 2 | PROPOSAL TO AMEND THE OSI PHARMACEUTICALS, INC. AMENDED AND RESTATED STOCK INCENTIVE PLAN. | Management | For | Against |
| 3 | PROPOSAL TO RATIFY THE APPOINTMENT OF KPMG LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF THE CORPORATION FOR THE FISCAL YEAR ENDING DECEMBER 31, 2005. | Management | For | For |
| ISSUER NAME: PHARMION CORPORATION MEETING DATE: 06/01/2005 | ||||
| TICKER: PHRM SECURITY ID: 71715B409 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1.1 | ELECT PATRICK J. MAHAFFY AS A DIRECTOR | Management | For | For |
| 1.2 | ELECT JAMES BLAIR AS A DIRECTOR | Management | For | For |
| 1.3 | ELECT CAM L. GARNER AS A DIRECTOR | Management | For | For |
| 2 | TO RATIFY THE SELECTION OF ERNST & YOUNG LLP AS THE CORPORATION S INDEPENDENT AUDITORS FOR THE FISCAL YEAR ENDING DECEMBER 31, 2005.1 | Management | For | For |
| 3 | TO APPROVE AN AMENDMENT TO THE COMPANY S 2000 STOCK INCENTIVE PLAN TO INCREASE BY 1,500,000 THE NUMBER OF SHARES OF COMMON STOCK RESERVED FOR ISSUANCE UNDER THE 2000 STOCK INCENTIVE PLAN. | Management | For | For |
| 4 | TO APPROVE AN AMENDMENT TO THE COMPANY S 2001 NON-EMPLOYEE DIRECTOR STOCK OPTION PLAN TO INCREASE BY 100,000 THE NUMBER OF SHARES OF COMMON STOCK RESERVED FOR ISSUANCE UNDER THE 2001 NON-EMPLOYEE DIRECTOR STOCK OPTION PLAN. | Management | For | For |
| 1. Fidelity displays agenda items and descriptions, including the use of characters (such as page numbers, percentage and pound signs, ampersands and, in particular, asterisks and other footnote designations) as they are provided by the issuer and the vote processing agent. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: PROTEIN DESIGN LABS, INC. MEETING DATE: 06/08/2005 | ||||
| TICKER: PDLI SECURITY ID: 74369L103 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1.1 | ELECT JON S. SAXE, ESQ. AS A DIRECTOR | Management | For | For |
| 1.2 | ELECT L. PATRICK GAGE, PH.D. AS A DIRECTOR | Management | For | For |
| 2 | TO APPROVE THE 2005 EQUITY INCENTIVE PLAN. | Management | For | For |
| 3 | TO AMEND THE 2002 OUTSIDE DIRECTORS STOCK OPTION PLAN. | Management | For | For |
| 4 | TO AMEND THE CERTIFICATE OF INCORPORATION TO CHANGE THE NAME OF THE COMPANY TO PDL BIOPHARMA, INC. | Management | For | For |
| 5 | TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2005.1 | Management | For | For |
| 6 | TO APPROVE ANY ADJOURNMENTS OF THE MEETING TO ANOTHER TIME OR PLACE, IF NECESSARY IN THE JUDGMENT OF THE PROXY HOLDERS, FOR THE PURPOSE OF SOLICITING ADDITIONAL PROXIES IN FAVOR OF ANY OF THE FOREGOING PROPOSALS. | Management | For | Abstain |
| 1. Fidelity displays agenda items and descriptions, including the use of characters (such as page numbers, percentage and pound signs, ampersands and, in particular, asterisks and other footnote designations) as they are provided by the issuer and the vote processing agent. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: REGENERON PHARMACEUTICALS, INC. MEETING DATE: 12/17/2004 | ||||
| TICKER: REGN SECURITY ID: 75886F107 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1 | PROPOSAL TO APPROVE THE AMENDMENT TO THE 2000 LONG-TERM INCENTIVE PLAN SET FORTH AS APPENDIX A TO THE ACCOMPANYING PROXY STATEMENT TO EXPRESSLY AUTHORIZE THE OPTION EXCHANGE PROGRAM DESCRIBED IN SUCH PROXY STATEMENT. | Management | For | Against |
| ISSUER NAME: REGENERON PHARMACEUTICALS, INC. MEETING DATE: 06/10/2005 | ||||
| TICKER: REGN SECURITY ID: 75886F107 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1.1 | ELECT A.G. GILMAN, M.D, PH.D. AS A DIRECTOR | Management | For | For |
| 1.2 | ELECT J.L. GOLDSTEIN, M.D. AS A DIRECTOR | Management | For | For |
| 1.3 | ELECT P. ROY VAGELOS, M.D. AS A DIRECTOR | Management | For | For |
| 2 | PROPOSAL TO RATIFY THE APPOINTMENT OF PRICEWATERHOUSECOOPERS LLP AS THE COMPANY S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2005. | Management | For | For |
| ISSUER NAME: SANOFI-AVENTIS MEETING DATE: 05/31/2005 | ||||
| TICKER: SNY SECURITY ID: 80105N105 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1 | APPROVAL OF THE INDIVIDUAL COMPANY FINANCIAL STATEMENTS | Management | For | None |
| 2 | APPROVAL OF THE CONSOLIDATED FINANCIAL STATEMENTS | Management | For | None |
| 3 | APPROPRIATION OF PROFITS; DECLARATION OF DIVIDEND | Management | For | None |
| 4 | APPROVAL OF TRANSACTIONS COVERED BY THE STATUTORY AUDITORS SPECIAL REPORT | Management | For | None |
| 5 | REAPPOINTMENT OF A STATUTORY AUDITOR | Management | For | None |
| 6 | REAPPOINTMENT OF A DEPUTY STATUTORY AUDITOR | Management | For | None |
| 7 | AUTHORIZATION TO THE BOARD OF DIRECTORS TO CARRY OUT TRANSACTIONS IN SHARES ISSUED BY THE COMPANY | Management | For | None |
| 8 | TERMINATION OF THE AUTHORITY TO ISSUE BONDS | Management | For | None |
| 9 | TO CARRY OUT INCREASES IN THE SHARE CAPITAL BY ISSUANCE, WITH PREEMPTIVE RIGHTS MAINTAINED | Management | For | None |
| 10 | TO CARRY OUT INCREASES IN THE SHARE CAPITAL BY ISSUANCE, WITHOUT PREEMPTIVE RIGHTS | Management | For | None |
| 11 | TO CARRY OUT INCREASES IN THE SHARE CAPITAL BY INCORPORATION OF SHARE PREMIUM, RESERVES, PROFITS OR OTHER ITEMS | Management | For | None |
| 12 | TO INCREASE THE NUMBER OF SHARES TO BE ISSUED IN THE EVENT OF A CAPITAL INCREASE WITH OR WITHOUT PREEMPTIVE RIGHTS | Management | For | None |
| 13 | TO CARRY OUT INCREASES IN THE SHARE CAPITAL BY ISSUANCE OF SHARES RESERVED FOR EMPLOYEES WITH WAIVER OF PREEMPTIVE RIGHTS | Management | For | None |
| 14 | DELEGATION TO THE BOARD OF DIRECTORS OF AUTHORITY TO GRANT OPTIONS TO SUBSCRIBE FOR OR PURCHASE SHARES | Management | For | None |
| 15 | DELEGATION TO THE BOARD TO ALLOT EXISTING OR NEW SHARES FREE OF CHARGE TO ALL OR SOME SALARIED EMPLOYEES OF THE GROUP | Management | For | None |
| 16 | DELEGATION TO THE BOARD OF DIRECTORS OF POWERS TO REDUCE THE SHARE CAPITAL BY CANCELLATION OF TREASURY SHARES | Management | For | None |
| 17 | POWERS FOR THE ACCOMPLISHMENT OF FORMALITIES | Management | For | None |
| ISSUER NAME: SEATTLE GENETICS, INC. MEETING DATE: 05/13/2005 | ||||
| TICKER: SGEN SECURITY ID: 812578102 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1.1 | ELECT DAVID W. GRYSKA AS A DIRECTOR | Management | For | For |
| 2 | PROPOSAL TO RATIFY THE APPOINTMENT OF PRICEWATERHOUSECOOPERS LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF THE COMPANY FOR THE FISCAL YEAR ENDING DECEMBER 31, 2005 | Management | For | For |
| 3 | PROPOSAL TO AMEND AND APPROVE THE COMPANY S 1998 STOCK OPTION PLAN | Management | For | For |
| ISSUER NAME: SEPRACOR INC. MEETING DATE: 05/19/2005 | ||||
| TICKER: SEPR SECURITY ID: 817315104 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1.1 | ELECT TIMOTHY J. BARBERICH AS A DIRECTOR | Management | For | For |
| 2 | TO APPROVE AN AMENDMENT TO OUR 2000 STOCK INCENTIVE PLAN INCREASING FROM 8,000,000 TO 9,500,000 THE NUMBER OF SHARES OF OUR COMMON STOCK RESERVED FOR ISSUANCE UNDER THE 2000 PLAN. | Management | For | Against |
| 3 | TO RATIFY THE SELECTION OF PRICEWATERHOUSECOOPERS LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE CURRENT FISCAL YEAR. | Management | For | For |
| ISSUER NAME: SEROLOGICALS CORPORATION MEETING DATE: 05/11/2005 | ||||
| TICKER: SERO SECURITY ID: 817523103 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1.1 | ELECT ROBERT J. CLANIN AS A DIRECTOR | Management | For | For |
| 1.2 | ELECT GERARD M. MOUFFLET AS A DIRECTOR | Management | For | For |
| 1.3 | ELECT LAWRENCE E. TILTON AS A DIRECTOR | Management | For | For |
| 2 | TO APPROVE THE 2005 INCENTIVE PLAN. | Management | For | For |
| 3 | TO AMEND THE AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF THE CORPORATION TO INCREASE THE NUMBER OF AUTHORIZED SHARES OF COMMON STOCK FROM 50,000,000 TO 115,000,000. | Management | For | For |
| 4 | TO RATIFY THE APPOINTMENT OF INDEPENDENT AUDITORS FOR THE FISCAL YEAR ENDED JANUARY 1, 2006. | Management | For | For |
| ISSUER NAME: SYNERON MEDICAL LTD. MEETING DATE: 06/22/2005 | ||||
| TICKER: ELOS SECURITY ID: M87245102 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1 | RE-ELECTION OF DIRECTOR DR. KREINDEL AS CLASS I DIRECTOR. | Management | For | For |
| 2 | RE-ELECTION OF DIRECTOR MR. MIZRAHY AS CLASS I DIRECTOR. | Management | For | For |
| 3 | RE-APPOINTMENT OF THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF KOST FORER GABBAY & KASIERER, A MEMBER OF ERNST & YOUNG GLOBAL AS THE INDEPENDENT AUDITORS OF THE COMPANY FOR THE 2005 FISCAL YEAR ENDING ON DECEMBER 31, 2005 AND AN ADDITIONAL PERIOD UNTIL THE NEXT ANNUAL GENERAL MEETING.1 | Management | For | For |
| 4 | AUTHORIZE THE BOARD, ACCORDING TO RECOMMENDATION OF THE AUDIT COMMITTEE, TO FIX THE INDEPENDENT AUDITORS REMUNERATION FOR AUDITING SERVICES AND FOR ADDITIONAL SERVICES. | Management | For | For |
| 5 | APPROVE THE SERVICE TERMS OF DR. SHIMON ECKHOUSE ACCORDING TO ISRAELI COMPANIES LAW 1999 REQUIREMENT FOR RELATED PARTIES TRANSACTIONS. | Management | For | For |
| 1. Fidelity displays agenda items and descriptions, including the use of characters (such as page numbers, percentage and pound signs, ampersands and, in particular, asterisks and other footnote designations) as they are provided by the issuer and the vote processing agent. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: TANOX, INC. MEETING DATE: 06/10/2005 | ||||
| TICKER: TNOX SECURITY ID: 87588Q109 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1.1 | ELECT HEINZ W. BULL AS A DIRECTOR | Management | For | For |
| 1.2 | ELECT TSE WEN CHANG AS A DIRECTOR | Management | For | For |
| ISSUER NAME: TECHNE CORPORATION MEETING DATE: 10/21/2004 | ||||
| TICKER: TECH SECURITY ID: 878377100 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1 | TO SET THE NUMBER OF DIRECTORS AT SIX. | Management | For | For |
| 2.1 | ELECT THOMAS E. OLAND AS A DIRECTOR | Management | For | For |
| 2.2 | ELECT ROGER C. LUCAS, PHD AS A DIRECTOR | Management | For | For |
| 2.3 | ELECT HOWARD V. O'CONNELL AS A DIRECTOR | Management | For | For |
| 2.4 | ELECT G. ARTHUR HERBERT AS A DIRECTOR | Management | For | For |
| 2.5 | ELECT RANDOLPH C STEER MD PHD AS A DIRECTOR | Management | For | For |
| 2.6 | ELECT ROBERT V. BAUMGARTNER AS A DIRECTOR | Management | For | For |
| ISSUER NAME: TELIK, INC. MEETING DATE: 05/26/2005 | ||||
| TICKER: TELK SECURITY ID: 87959M109 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1.1 | ELECT EDWARD W. CANTRALL, PHD AS A DIRECTOR | Management | For | For |
| 1.2 | ELECT STEVEN R. GOLDRING, MD AS A DIRECTOR | Management | For | For |
| 2 | TO RATIFY THE SELECTION OF ERNST & YOUNG LLP AS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF THE COMPANY FOR ITS FISCAL YEAR ENDING DECEMBER 31, 2005.1 | Management | For | For |
| 1. Fidelity displays agenda items and descriptions, including the use of characters (such as page numbers, percentage and pound signs, ampersands and, in particular, asterisks and other footnote designations) as they are provided by the issuer and the vote processing agent. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: THE MEDICINES COMPANY MEETING DATE: 05/25/2005 | ||||
| TICKER: MDCO SECURITY ID: 584688105 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1.1 | ELECT CLIVE A. MEANWELL AS A DIRECTOR | Management | For | For |
| 1.2 | ELECT ROBERT J. HUGIN AS A DIRECTOR | Management | For | For |
| 1.3 | ELECT ELIZABETH H.S. WYATT AS A DIRECTOR | Management | For | For |
| 2 | RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE YEAR ENDING DECEMBER 31, 2005.1 | Management | For | For |
| 3 | APPROVE THE AMENDMENT TO THE COMPANY S CERTIFICATE OF INCORPORATION TO INCREASE THE AUTHORIZED NUMBER OF SHARES OF COMMON STOCK. | Management | For | For |
| 1. Fidelity displays agenda items and descriptions, including the use of characters (such as page numbers, percentage and pound signs, ampersands and, in particular, asterisks and other footnote designations) as they are provided by the issuer and the vote processing agent. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: VIACELL, INC. MEETING DATE: 06/09/2005 | ||||
| TICKER: VIAC SECURITY ID: 92554J105 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1.1 | ELECT BARBARA BIERER AS A DIRECTOR | Management | For | For |
| 1.2 | ELECT DENISE POLLARD-KNIGHT AS A DIRECTOR | Management | For | For |
| 1.3 | ELECT JAMES TULLIS AS A DIRECTOR | Management | For | For |
| ISSUER NAME: XOMA LTD. MEETING DATE: 05/19/2005 | ||||
| TICKER: XOMA SECURITY ID: G9825R107 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1.1 | ELECT JAMES G. ANDRESS AS A DIRECTOR | Management | For | For |
| 1.2 | ELECT WILLIAM K. BOWES, JR. AS A DIRECTOR | Management | For | For |
| 1.3 | ELECT JOHN L. CASTELLO AS A DIRECTOR | Management | For | For |
| 1.4 | ELECT PETER B. HUTT AS A DIRECTOR | Management | For | For |
| 1.5 | ELECT ARTHUR KORNBERG, M.D. AS A DIRECTOR | Management | For | For |
| 1.6 | ELECT P.J. SCANNON, MD, PH.D AS A DIRECTOR | Management | For | For |
| 1.7 | ELECT W. DENMAN VAN NESS AS A DIRECTOR | Management | For | For |
| 1.8 | ELECT PATRICK J. ZENNER AS A DIRECTOR | Management | For | For |
| 2 | PROPOSAL TO APPOINT ERNST & YOUNG LLP TO ACT AS THE COMPANY S INDEPENDENT AUDITORS FOR THE 2005 FISCAL YEAR AND AUTHORIZE THE BOARD TO AGREE TO SUCH AUDITORS FEE.1 | Management | For | For |
| 3 | PROPOSAL TO APPROVE THE INCREASE OF THE COMPANY S AUTHORIZED SHARE CAPITAL BY THE CREATION OF AN ADDITIONAL 75,000,000 COMMON SHARES, AS DESCRIBED IN THE PROXY STATEMENT. | Management | For | For |
| 1. Fidelity displays agenda items and descriptions, including the use of characters (such as page numbers, percentage and pound signs, ampersands and, in particular, asterisks and other footnote designations) as they are provided by the issuer and the vote processing agent. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||